FLGT Q2 2018 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q2 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$5M+16.4% YoY

Gross Profit

$3M52.9% margin

Operating Income

-$1M-18.5% margin

Net Income

-$1M-19.4% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+16.1%

Cash Flow

Operating Cash Flow

-$57,000

Free Cash Flow

-$603,000

Stock-Based Comp.

$573,000

Balance Sheet

Total Assets

$56M

Total Liabilities

$3M

Stockholders' Equity

$53M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	+16.4%
Gross Profit	$3M	$3M	+3.4%
Operating Income	-$1M	-$150,000	-567.3%
Net Income	-$1M	-$25,000	-4096.0%

Geographic Segments

UNITED STATES

$3M61%

CANADA

$1M20%

Other Countries

$1M19%

CHINA

$25,0000%